Course / Course Summary and a Framework on Decision Making
Introduction
Fertility preservation before cancer treatment is an increasingly vital part of comprehensive reproductive care. Advances in cryopreservation, ovarian tissue banking, and assisted reproductive technologies (ART) have made it possible for patients to safeguard their ability to build a family post-recovery.
As fertility specialists, we guide patients through clinical and ethical decisions, balancing medical urgency, long-term family-building goals, and treatment safety.
This course outlines the key considerations fertility experts evaluate when planning fertility preservation for oncology patients.
Understanding Reproductive Intentions
Before initiating preservation, the fertility team must assess the individual’s reproductive goals:
Does the patient intend to have biological children in the future?
What is the desired number of children?
Is there a partner involved, and what are their reproductive intentions?
Is third-party reproduction (donor gametes or gestational carrier) acceptable if needed later?
A clear understanding of these factors helps tailor the preservation approach—whether that’s egg, embryo, or sperm freezing—and determines if concurrent partner involvement or donor options should be considered.
Aligning with Oncologic Timelines
For many cancer patients, treatment must begin quickly. Fertility experts collaborate closely with oncologists to design time-sensitive protocols—such as random-start ovarian stimulation—to ensure fertility preservation does not compromise cancer care.
Assessing the Impact of Cancer Treatment
Chemotherapy, radiation, and surgical interventions can severely impair reproductive function.
Ovarian Reserve Damage: Alkylating agents and pelvic radiation can cause premature ovarian insufficiency.
Testicular Failure: Cytotoxic drugs may reduce sperm production or cause permanent azoospermia.
Uterine Damage: Radiation can affect uterine vasculature and endometrial receptivity.
Predictive Testing
Before preservation, baseline fertility evaluations (AMH, antral follicle count, semen analysis) help quantify risk and guide urgency.
Understanding the degree of potential gonadotoxicity helps set realistic expectations for success rates.
Pregnancy and Health Prognosis
In some cancer types—especially hormone-sensitive malignancies such as breast or endometrial cancers—future pregnancy or hormonal stimulation can pose risks.
Fertility specialists use modified stimulation protocols (e.g., letrozole-based) to minimize estrogen exposure.
Genetic and Offspring Health Considerations
Certain cancers have hereditary components (e.g., BRCA mutations, Lynch syndrome). Preimplantation genetic testing (PGT-M) may be recommended to reduce transmission risks.
This also ensures embryos selected for transfer are chromosomally normal and free of known pathogenic variants.
Oncologic Safety
Every fertility preservation plan must align with the patient’s oncologic prognosis and recovery pathway. The aim is always to preserve fertility safely, without delaying or compromising cancer treatment outcomes.
Financial and Logistical Support
Fertility preservation can be costly, but numerous nonprofit organizations, hospital foundations, and pharmaceutical programs offer assistance. Examples include:
Livestrong Fertility
Heart Beat Program
Fertile Hope
Local hospital foundations and cancer centers
Many insurance providers are also expanding coverage for iatrogenic infertility. At Surrogacy4All, we assist patients in navigating financial aid and coordinating with partner fertility clinics across the USA.
Multidisciplinary Collaboration
A successful fertility preservation program involves:
Oncologists, ensuring timing safety
Reproductive endocrinologists, managing protocol design
Genetic counselors, evaluating hereditary risks
Embryologists, performing vitrification and storage
Psychologists or social workers, supporting emotional and ethical aspects
Surrogacy4All maintains a nationwide network of reproductive specialists, ensuring patients have access to leading-edge expertise regardless of location.
Success Rates and Variables
Success in fertility preservation depends on:
Age at preservation: Younger patients have higher egg/sperm quality.
Treatment timeline: Shorter intervals between diagnosis and cryopreservation improve outcomes.
Type of cancer and therapy: Certain treatments pose less reproductive risk than others.
For women, survival of thawed oocytes is typically >90% with modern vitrification. For men, sperm cryopreservation success rates are exceptionally high. Embryo cryopreservation remains the most established and effective method overall.
Post-Treatment Reproductive Pathways
After remission, preserved gametes or embryos can be used for:
IVF with own uterus, if medically safe.
Gestational surrogacy, when pregnancy is contraindicated.
Donor egg or sperm use, if original gametes were not viable.
Surrogacy4All’s medical and legal teams specialize in helping survivors safely achieve parenthood, whether through assisted reproduction or gestational carrier arrangements.
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Surrogacy4All is a unique international surrogacy service targeted at providing state of the art IVF and surrogacy services to Intended Parents irrespective of age, sex or color, at the lowest possible cost in the world.
Secret Guide to Minimizing Surrogacy Costs
All Rights Reserved to Surrogacy4all